Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 BNS Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operating Performance ACR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Commercial Real Estate Environment SPME Q1 2026 Earnings Preferred Shares Miss EPS Estimates Stock Declines Garmin Q1 2026 Earnings EPS Beats Estimates by 12 Shares Edge Higher Enel Chile Q4 2025 Earnings EPS Beats Estimates by 281 Amidst Operational Resilience